Clinical Trial Update

Category
Continent
From
To
 
ENGULF Study Demonstrates Strong Safety and Effica...

ENGULF Study Demonstrates Strong Safety and Effica...

Category : Clinical Trial Update 4 November 2025

Results from the pivotal cohort of the ENGULF Investigational Device Exemption (IDE) study evaluatin...
New Findings on Transdermal Curcumin Gel Show Prom...

New Findings on Transdermal Curcumin Gel Show Prom...

Category : Clinical Trial Update 4 November 2025

Researchers will present new findings demonstrating that a novel transdermal curcumin gel (VAS-101;...
Gefurulimab Meets Primary and Secondary Endpoints...

Gefurulimab Meets Primary and Secondary Endpoints...

Category : Clinical Trial Update 3 November 2025

Positive topline results from the global PREVAIL Phase III trial showed that gefurulimab achieved bo...
GC Biopharma Publishes Phase 2 Results of World’s...

GC Biopharma Publishes Phase 2 Results of World’s...

Category : Clinical Trial Update 3 November 2025

Study demonstrates strong immunogenicity and favorable safety profile for BARYTHRAX inj. (GC1109)...
REGENXBIO Completes Enrollment in Pivotal Duchenne...

REGENXBIO Completes Enrollment in Pivotal Duchenne...

Category : Clinical Trial Update 1 November 2025

REGENXBIO Inc. has reached two major milestones in its Duchenne muscular dystrophy (DMD) program &md...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!